尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Announcement In Relation To Approval Of The Proposed A Shares Issue By HHC
2021-04-27
2020 Corporate Social Responsibility Report
2021-04-26
Annual Report 2020
2021-04-26
Appointment of Independent Financial Adviser
2021-04-19
Overseas Regulatory Announcement
2021-04-15
Overseas Regulatory Announcement
2021-04-14
Overseas Regulatory Announcement
2021-04-14
Overseas Regulatory Announcement
2021-04-14
Overseas Regulatory Announcement
2021-04-14
Overseas Regulatory Announcement
2021-04-14
<
...
4
5
6
7
8
9
10
...
>